Answers are grounded in this paper and cite their sources.
A therapeutic renaissance in the history of cancer therapy has been unfolding with the recent development of what has been termed the ‘novel agents’ for the treatment of multiple myeloma.
No takes yet. Share an insight, caveat, or question.
Mark et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: